Search for Clinical Trial Results
Polycythemia Vera - 30 Studies Found
Status | Study |
Completed |
Study Name: Study to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera Patients Condition: Polycythemia Vera Date: 2015-06-12 Interventions: Drug: Pegylated-Proline-Interferon alpha-2b in a Pre-filled Pen Subjects will continue to receive the do |
Completed |
Study Name: Effects of Imatinib Mesylate in Polycythemia Vera Condition: Polycythemia Vera Date: 2007-01-31 Interventions: Drug: Imatinib Mesylate 400 mg/die for 6 months |
Active, not recruiting |
Study Name: AOP2014 vs. BAT in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study. Condition: Polycythemia Vera Date: 2014-08-14 Interventions:
|
Active, not recruiting |
Study Name: Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy. Condition: Polycythemia Vera Date: 2014-01-14 Interventions:
|
Terminated |
Study Name: Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera Condition: Polycythemia Vera Date: 2009-12-22 Interventions: Drug: Erlotinib Erlotinib supplied as tablets; oral dose of erlotinib of 150 mg daily to be continued fo |
Completed |
Study Name: Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia Vera Condition: Polycythemia Vera Date: 2013-09-06 Interventions:
|
Terminated |
Study Name: Large-scale Trial Testing the Intensity of CYTOreductive Therapy in Polycythemia Vera (PV) Condition: Polycythemia Vera Date: 2012-07-17 Interventions:
|
Active, not recruiting |
Study Name: Safety Study of Pegylated Interferon Alpha 2b to Treat Polycythemia Vera Condition: Polycythemia Vera Date: 2010-09-01 Interventions: Drug: PEG-P-INF alpha-2b (P1101) µg (starting with 50 µg), subcutaneously, 2-weekly administra |
Withdrawn |
Study Name: Clopidogrel and Aspirin for the Treatment of Polycythemia Vera Condition: Polycythemia Vera Date: 2009-07-14 Interventions:
|
Active, not recruiting |
Study Name: Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial) Condition: Polycythemia Vera Date: 2010-11-17 Interventions:
|